Safety of daily dose esomeprazole for GERD for pediatric and adolescent patients

Exclusion Criteria

• - Patients who have used a PPI within 14 days prior to randomization, including over-the-counter Prilosec®.
• - Patients who have used any prescription or over-the-counter treatment for symptoms of gastroesophageal reflux disease (GERD), such as Histamine 2 Receptor Antagonists (H2RA) or prokinetics, within 3 days prior to randomization. Antacids may be used, except for those containing bismuth.
• - Patients with a known hypersensitivity, allergy, or intolerance to any component of esomeprazole or omeprazole.